City

Chapel Hill (1)

Chicago (1)

Nashville (1)

New York (1)

Philadelphia (1)

Tampa (1)

Toronto (1)

Condition

Recurrent Thyroid Gland Carcinoma (2)

Stage III Thyroid Gland Papillary Carcinoma (2)

Stage IV Thyroid Gland Papillary Carcinoma (2)

Stage I Thyroid Gland Papillary Carcinoma (1)

Stage II Thyroid Gland Papillary Carcinoma (1)

Stage III Thyroid Gland Follicular Carcinoma (1)

Stage IV Thyroid Gland Follicular Carcinoma (1)

Overall Status

Completed (2)

Sign in for free

Phase

phase 2 (2)

Sponsor

National Cancer Institute (NCI) (2)

Collaborator

Intervention

laboratory biomarker analysis (2)

fludeoxyglucose f-18 (1)

pharmacological study (1)

positron emission tomography (1)

selumetinib (1)

ziv-aflibercept (1)

Study Documents

Intervention Type

other (2)

biological (1)

drug (1)

procedure (1)

radiation (1)

Funder Type

NIH (2)

Study Type

Interventional (2)

stage iv thyroid gland papillary carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Recurrent Thyroid Gland Carcinoma, Stage III Thyroid Gland Follicular Carcinoma, Stage III Thyroid Gland Papillary Carcinoma

Completed

Has Results

Recurrent Thyroid Gland Carcinoma
+4 more

Fludeoxyglucose F-18
+4 more

New York, New York

Memorial Sloan-Kettering Cancer Center

Jan 24, 2017

Recurrent Thyroid Gland Carcinoma, Stage I Thyroid Gland Papillary Carcinoma, Stage II Thyroid Gland Papillary Carcinoma Trial

Completed

Has Results

Recurrent Thyroid Gland Carcinoma
+4 more

Laboratory Biomarker Analysis
Selumetinib

Tampa, Florida
+5 more

Dec 2, 2016